newsfilter
← Latest News
ACCESS Newswire·

Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety

TORONTO, ON / ACCESSWIRE / March 16, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce it has been selected by Mind Medicine, Inc